University of Colorado, Denver
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).
University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.
University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.
Top-decile sponsor footprint
University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,283 total, page 3 of 26
Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.
NCT06357442
Digital Health Physical Activity Program for Older Family Care Partners of Patents With Heart Failure
NCT05852509
Effects of THC on Alcohol Consumption and Neural Correlates of Reward
NCT06446479
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
NCT05935826
Cardiometabolic Consequences of the Loss of Ovarian Function
NCT06264882
Vending Machine Naloxone Distribution for Your Community (VENDY)
NCT06429436
MIRA CONNECT Study
NCT06802263
Evaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease
NCT06446505
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
NCT06141447
Genetic Regulators of Bone Health That Are Unique to Vertebral Bone
NCT05946278
Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes
NCT06297980
Prevention and Treatment of Frostbite Infection With Antimicrobial Pharmacokinetic Analysis
NCT06266494
Feasibility of Cough Monitoring in Children
NCT06587126
Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors
NCT06324981
Swelling Management After Knee Replacement
NCT06095401
Cladribine Venetoclax in Monocytic AML
NCT06232655
Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation
NCT06244719
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
NCT06140537
UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1
NCT05535855
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
NCT06397677
CBD for Individuals at Risk for Alzheimer's Disease
NCT05822362
V+PSF-M for Tobacco Cessation in HIV Care in India
NCT05786547
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
NCT06129110
Advair HFA in Healthy and HAPE Predisposed Subjects
NCT06040268
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
NCT06116435
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
NCT05969496
PCOM2 - The Physician Communication Intervention, Version 2.0
NCT05336240
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
NCT05819853
Shingrix In Recipients of Allogeneic Transplants
NCT05775718
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
NCT05887609
Reducing Asthma Attacks in Disadvantaged School Children With Asthma
NCT06003569
Pediatric Medication Therapy Management Trial
NCT05761847
PRC With Meniscal Allograft Arthroplasty for Wrist Osteoarthritis
NCT05412615
One-4-ALL Initiative
NCT05454969
A Comparison of Two School Based Interventions to Manage Anxiety in Autistic Students
NCT05863520
Identifying Right Ventricular Dysfunction in COPD Through Right Heart Catheterization, Imaging and Exercise
NCT05896579
Parenting Skills Group for Mothers With Postpartum Depression
NCT05772897
Early vs. Late Time Restricted Eating vs. Daily Caloric Restriction
NCT05870982
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
NCT05819138
ENRICH Nurse-Family Partnership Study
NCT05798039
Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer
NCT05840263
Alcohol Use Disorder and Cannabidiol
NCT05613608
TelePrEP for At-risk Youth in Colorado
NCT05520905
Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
NCT05877391
Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation
NCT05259904
Acute Equol Supplementation and Vascular Function in Women With and Without CKD
NCT06128278
Shingrix in Renal Transplant Recipients
NCT04128189
Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity
NCT05566483
Pancreas Ultrasound Imaging in type1 Diabetes
NCT05482321
Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer
NCT05524610
What is open in the University of Colorado, Denver pipeline
265 recruiting of 1,283 indexed (21% open); 830 completed (65%).
Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).
Top condition: Obesity (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Denver: open-pipeline peers nationwide
Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,283 trials (± recruiting share)
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Michigan · 1,327 trials · 13% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- Eli Lilly and Company · 1,341 trials · 9% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Cedars-Sinai Medical Center · 21% recruiting · 339 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this University of Colorado, Denver page
1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.
- 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.